|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-25
|
|
pubmed:abstractText |
Arteriosclerosis obliterans (ASO) in hemodialysis patients is the dominant cause of morbidity evolving from arteriosclerosis. Adiponectin is an adipose-derived cytokine which, because of its modulation of endothelial adhesion molecules, has potential anti-inflammatory and anti-atherogenic properties. However, the implications of adiponectin and endothelial function in ASO of hemodialysis patients has not been fully elucidated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1342-1751
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
58-64
|
|
pubmed:meshHeading |
pubmed-meshheading:18175063-Adiponectin,
pubmed-meshheading:18175063-Adult,
pubmed-meshheading:18175063-Aged,
pubmed-meshheading:18175063-Aged, 80 and over,
pubmed-meshheading:18175063-Antigens, CD146,
pubmed-meshheading:18175063-Arteriosclerosis Obliterans,
pubmed-meshheading:18175063-Endothelial Cells,
pubmed-meshheading:18175063-Female,
pubmed-meshheading:18175063-Humans,
pubmed-meshheading:18175063-Kidney Failure, Chronic,
pubmed-meshheading:18175063-Male,
pubmed-meshheading:18175063-Middle Aged,
pubmed-meshheading:18175063-Renal Dialysis,
pubmed-meshheading:18175063-Retrospective Studies
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Serum adiponectin and markers of endothelial injury in hemodialysis patients with arteriosclerosis obliterans.
|
|
pubmed:affiliation |
Department of Nephrology, Jichi Medical University, Simotsuke, Tochigi 329-0498, Japan. nephsait@jichi.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
